Free Trial
ASX:VN8

Vonex (VN8) Stock Price, News & Analysis

About Vonex Stock (ASX:VN8)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
230,330 shs
Average Volume
N/A
Market Capitalization
A$27.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VN8 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vonex and its competitors with MarketBeat's FREE daily newsletter.

VN8 Stock News Headlines

How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
Koinswap is launching its own layer-1 blockchain.
See More Headlines

VN8 Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Vonex investors own include Recce Pharmaceuticals (RCE) and Burford Capital (BUR).

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Telecom Services
Sub-Industry
N/A
Current Symbol
ASX:VN8
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$1.34 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$48.19 million
Price / Cash Flow
6.18
Book Value
A($0.01) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$27.09 million
Optionable
Not Optionable
Beta
1.12
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:VN8) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners